Flow Cytometry and Confocal Microscopy Shared Resource
流式细胞术和共焦显微镜共享资源
基本信息
- 批准号:10625766
- 负责人:
- 金额:$ 7.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAccountingAdherenceAntibodiesApplications GrantsBackBiological MarkersBiometryBiotechnologyBrainCOVID-19 pandemicCancer CenterCancer Center Support GrantCancer ControlCell SeparationCellsCellular MorphologyCertificationChargeClinicalCollaborationsCommunitiesComplexConfocal MicroscopyConsultationsDataData AnalysesDevelopmentDoctor of PhilosophyEducational workshopEffectivenessEnsureEquipmentExperimental DesignsFeedbackFloridaFlow CytometryFundingFutureGenetic ResearchGrowthHealthHourImageImmuneImmune responseImmunobiologyImmunologistImmunophenotypingImmunotherapyInfrastructureInstitutionKnowledgeLaboratoriesLasersLast NameLettersMalignant NeoplasmsMethodsMicroscopyMissionModernizationNCI Center for Cancer ResearchPeer ReviewPhenotypePoliciesPopulation SciencesPostdoctoral FellowProceduresProductivityPublicationsRNA vaccineRecommendationReproducibilityResearchResearch ActivityResearch Project GrantsResearch SupportReservationsResource SharingResourcesSamplingScanningScienceServicesSolid NeoplasmSortingStrategic PlanningStudentsSurfaceSurface AntigensSurveysSystemTechnologyTissuesTrainingUnited States National Institutes of HealthUniversitiesVaccine Clinical TrialVendoranticancer researchcostcost effectivedesignexosomeexperiencefirst-in-humanfluorescence microscopeimprovedinstrumentinstrumentationlive cell imagingmembermulti-photonoperationparticleprogramsrecruitresponsesatisfactionsingle cell analysisstudent trainingtime usetreatment responsetumorigenesisultra high resolution
项目摘要
FLOW CYTOMETRY AND CONFOCAL MICROSCOPY SHARED RESOURCE (CYT-SR): ABSTRACT
CYT-SR provides University of Florida Health Cancer Center (UFHCC) members with cost-effective, state-of-
the-art flow cytometry and modern confocal microscopy expertise, instrumentation, and services to support their
research activities. The CYT-SR is an institutionally-managed shared resource (SR) that is supported by UFHCC
through a partnership with the UF Interdisciplinary Center for Biotechnology Research (ICBR). It is co-located
within the Cancer & Genetics Research Complex and McKnight Brain Institute, providing convenient access for
UFHCC members. The CYT-SR has 4 staff with over 22 years combined experience including Kellish, the
Scientific Director, an immunologist with more than 7 years of experience in all aspects of flow analysis. Key
technologies available in the CYT-SR include multi-parameter flow cytometry, cell sorting, live cell imaging via
confocal microscopy, surface biomarker-based cancer and immune cell phenotyping, assessment of tissue and
cell morphology by confocal microscopy, and small particle and exosome analysis. During the recent COVID-19
pandemic, the CYT-SR was identified as an essential campus resource and remained open and accessible to
all users. Instrument reservations, equipment usage time, and technician-assisted activities are tracked by the
UFHCC and charged back via the CrossLab laboratory management system. Since 2016, the CYT-SR was
utilized by 78 unique UFHCC users (43 with peer-reviewed funding) accounting for ~24% of all users of the
facility. CYT-SR use by UFHCC members increased 5.3-fold from 900 hours in 2016 to 4,800 hours in 2021.
The CYT-SR supported more than 180 publications, with 24% having IF >10. Since the 2019 CCSG submission,
484 students, postdoctoral fellows, and technical staff from UFHCC member laboratories were trained on CYT-
SR instruments. Mechanisms of Oncogenesis and the Cancer Therapeutics and Host Response members
represent the majority of UFHCC users. The effectiveness of the CYT-SR in enhancing member research
productivity is assessed by annual surveys, feedback from the CYT-SR Scientific Advisory Group, and
recommendations from the SR Oversight Committee. Due to the rising demand for CYT-SR resources by
members, the UFHCC supported the purchase of a new Sony SP6800 Spectral Analyzer (2018), Cytoflex LX21
(2020), and a Becton Dickinson SYMPHONY A3 (2020). To support first-in-human RNA vaccine clinical trials,
UFHCC supported the recruitment of a PhD-level immunologist to the CYT-SR to perform flow-based
immunophenotyping. Future growth of the CYT-SR are in alignment with the UFHCC strategic plan, Momentum
2027, and user satisfaction surveys, and include upgrades such as an acquisition of a BD FACSYMPHONY S6
cell sorter, increasing capabilities and services in super high-resolution microscopy and single cell analysis, and
in collaboration with BQS-SR, expansion of advanced training in the application of biostatistics to cytometric
analysis.
流式细胞仪和共聚焦显微镜共享资源(CYT-SR):摘要
Cyt-SR为佛罗里达大学健康癌症中心(UFHCC)成员提供成本效益,最新
ART流式细胞术和现代共聚焦显微镜专业知识,仪器和服务以支持其
研究活动。 CYT-SR是由UFHCC支持的机构管理的共享资源(SR)
通过与UF跨学科生物技术研究中心(ICBR)的合作关系。它是共同的
在癌症与遗传学研究院和麦克奈特脑研究所中,为方便的访问提供了
UFHCC成员。 Cyt-SR拥有4位员工,拥有超过22年的合并经验,包括Kellish,
科学总监,一名免疫学家,在流动分析的各个方面拥有超过7年的经验。钥匙
Cyt-SR中可用的技术包括多参数流式细胞术,细胞分类,通过活细胞成像通过
共聚焦显微镜,基于表面生物标志物的癌症和免疫细胞表型,组织和
共聚焦显微镜以及小颗粒和外泌体分析的细胞形态。在最近的Covid-19期间
大流行,Cyt-SR被确定为必不可少的校园资源,并保持开放和访问
所有用户。仪器预订,设备使用时间和技术人员辅助活动由
UFHCC并通过CrossLab实验室管理系统充电。自2016年以来,Cyt-SR是
由78个唯一的UFHCC用户(43个具有同行评审的资金)使用,占所有用户的24%
设施。 UFHCC成员使用的CYT-SR使用率从2016年的900小时增加到5.3倍,增加到2021年的4,800小时。
Cyt-SR支持了180多个出版物,其中24%的IF> 10。自2019年CCSG提交以来,
484名学生,博士后研究员和来自UFHCC成员实验室的技术人员接受过培训。
SR仪器。肿瘤发生和癌症治疗和宿主反应成员的机制
代表大多数UFHCC用户。 CYT-SR在增强成员研究方面的有效性
生产率通过年度调查,CYT-SR科学咨询小组的反馈以及
SR监督委员会的建议。由于对Cyt-SR资源的需求不断增加
成员,UFHCC支持购买新的Sony SP6800 Spectral Analyzer(2018),CytoFlex LX21
(2020)和Becton Dickinson Symphony A3(2020)。为了支持首次人类RNA疫苗临床试验,
UFHCC支持将PHD级免疫学家招募到CYT-SR,以执行基于流量的
免疫表型。 Cyt-SR的未来增长与UFHCC战略计划保持一致
2027年和用户满意度调查,并包括升级,例如收购BD FACSYMPHONY S6
细胞分类器,超高分辨率显微镜和单细胞分析中的功能和服务的增加,以及
与BQS-SR合作,在应用生物统计学中扩展高级培训
分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Kellish其他文献
Patrick Kellish的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Faith-Based Approaches in the Treatment of Hypertension (FAITH)
基于信仰的高血压治疗方法 (FAITH)
- 批准号:
8307676 - 财政年份:2009
- 资助金额:
$ 7.83万 - 项目类别:
Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report?
癌症后自我评价增强:幸存者自我报告存在偏见?
- 批准号:
7752638 - 财政年份:2009
- 资助金额:
$ 7.83万 - 项目类别:
Faith-Based Approaches in the Treatment of Hypertension (FAITH)
基于信仰的高血压治疗方法 (FAITH)
- 批准号:
8509770 - 财政年份:2009
- 资助金额:
$ 7.83万 - 项目类别:
Faith-Based Approaches in the Treatment of Hypertension (FAITH)
基于信仰的高血压治疗方法 (FAITH)
- 批准号:
7926913 - 财政年份:2009
- 资助金额:
$ 7.83万 - 项目类别:
Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report?
癌症后自我评价增强:幸存者自我报告存在偏见?
- 批准号:
7877031 - 财政年份:2009
- 资助金额:
$ 7.83万 - 项目类别: